Oramed Pharmaceuticals (Israel) Analysis
| ORMP Stock | 8.63 0.02 0.23% |
Oramed Pharmaceuticals is overvalued with Real Value of 7.35 and Hype Value of 8.63. The main objective of Oramed Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Oramed Pharmaceuticals is worth, separate from its market price. There are two main types of Oramed Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Oramed Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Oramed Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The Oramed Pharmaceuticals stock is traded in Israel on Tel Aviv Stock Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Sun except for officially observed holidays in Israel. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Oramed Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
Oramed |
Oramed Stock Analysis Notes
The company recorded a loss per share of 0.87. Oramed Pharmaceuticals had not issued any dividends in recent years. Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York. ORAMED PHARMA is traded on Tel Aviv Stock Exchange in Israel. To find out more about Oramed Pharmaceuticals contact the company at 844-967-2633 or learn more at http://www.oramed.com.Oramed Pharmaceuticals Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Oramed Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Oramed Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Oramed Pharmaceuticals generated a negative expected return over the last 90 days | |
| Oramed Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 2.64 M. Net Loss for the year was (15 M) with profit before overhead, payroll, taxes, and interest of 2.54 M. | |
| Oramed Pharmaceuticals has accumulated about 26.19 M in cash with (14.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.51. |
Oramed Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 189.3 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Oramed Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Oramed Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 29th of November, Oramed Pharmaceuticals holds the Variance of 7.01, coefficient of variation of (2,217), and Risk Adjusted Performance of (0.03). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Oramed Pharmaceuticals, as well as the relationship between them.Oramed Pharmaceuticals Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Oramed Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Oramed Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Oramed Pharmaceuticals Predictive Daily Indicators
Oramed Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Oramed Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.0115 | |||
| Daily Balance Of Power | 0.2 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 8.64 | |||
| Day Typical Price | 8.64 | |||
| Market Facilitation Index | 0.1 | |||
| Period Momentum Indicator | 0.02 |
Oramed Pharmaceuticals Forecast Models
Oramed Pharmaceuticals' time-series forecasting models are one of many Oramed Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Oramed Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Oramed Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Oramed Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Oramed shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Oramed Pharmaceuticals. By using and applying Oramed Stock analysis, traders can create a robust methodology for identifying Oramed entry and exit points for their positions.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York. ORAMED PHARMA is traded on Tel Aviv Stock Exchange in Israel.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Oramed Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
| All Next | Launch Module |
Complementary Tools for Oramed Stock analysis
When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |